- Home
- OMH vs PBM Comparison
OMH vs PBM Comparison
Compare OMH & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- PBM
- Stock Information
- Founded
- OMH 2015
- PBM 1994
- Country
- OMH Singapore
- PBM Canada
- Employees
- OMH N/A
- PBM N/A
- Industry
- OMH Real Estate
- PBM
- Sector
- OMH Finance
- PBM
- Exchange
- OMH Nasdaq
- PBM NYSE
- Market Cap
- OMH 4.6M
- PBM 5.3M
- IPO Year
- OMH 2023
- PBM N/A
- Fundamental
- Price
- OMH $2.11
- PBM $0.46
- Analyst Decision
- OMH Strong Buy
- PBM
- Analyst Count
- OMH 1
- PBM 0
- Target Price
- OMH $15.00
- PBM N/A
- AVG Volume (30 Days)
- OMH 404.8K
- PBM 103.5K
- Earning Date
- OMH 01-01-0001
- PBM 05-06-2025
- Dividend Yield
- OMH N/A
- PBM N/A
- EPS Growth
- OMH N/A
- PBM N/A
- EPS
- OMH N/A
- PBM N/A
- Revenue
- OMH $5,390,607.00
- PBM N/A
- Revenue This Year
- OMH $102.52
- PBM N/A
- Revenue Next Year
- OMH $37.92
- PBM N/A
- P/E Ratio
- OMH N/A
- PBM N/A
- Revenue Growth
- OMH 25.77
- PBM N/A
- 52 Week Low
- OMH $0.25
- PBM $0.37
- 52 Week High
- OMH $3.35
- PBM $108.00
- Technical
- Relative Strength Index (RSI)
- OMH 49.97
- PBM 34.91
- Support Level
- OMH $1.70
- PBM $0.39
- Resistance Level
- OMH $3.77
- PBM $0.48
- Average True Range (ATR)
- OMH 0.44
- PBM 0.07
- MACD
- OMH -0.04
- PBM 0.02
- Stochastic Oscillator
- OMH 19.81
- PBM 44.81
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.